Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia

Gynecologic Oncology

Volumn 82, Issue 2, 2001, Pages 367-370

  Kwon, Janice S ^a   Elit, Laurie ^a,b   Mazurka, John ^b   Moens, Francois ^b   Schmuck, Mary Lou ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Complete response; Gestational trophoblastic neoplasia; Weekly intravenous methotrexate; hCG titer

Indexed keywords

ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN BETA SUBUNIT; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE;

ADULT; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CHORIOCARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; GASTROINTESTINAL TOXICITY; GYNECOLOGIC CANCER; HUMAN; NEPHROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; TROPHOBLASTIC DISEASE;

EID: 0034898123     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6271     Document Type: Article

References (23)

1. Effects of methotrexate therapy upon choriocarcinoma and chorioadenomas
2. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms
3. Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease
4. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease
5. Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease
6. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia
7. Results of low-dose methotrexate treatment of persistent gestational trophoblastic disease in Sheffield 1980-1987
8. The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT)
9. Treatment of nonmetastatic gestational trophoblastic disease with sequential intramuscular and oral methotrexate
10. Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors
11. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy
12. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors
13. High-dose methotrexate for gestational trophoblastic disease
14. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease
15. Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: A Gynecologic Oncology Group study
16. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate folinic acid
17. A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease
18. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer
19. The clinical pharmacology of methotrexate: New applications of an old drug
20. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity
21. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia
22. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia